Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$51.22 - $60.16 $15,366 - $18,048
-300 Reduced 4.69%
6,100 $322,000
Q2 2024

Aug 14, 2024

BUY
$47.86 - $75.05 $14,358 - $22,515
300 Added 4.92%
6,400 $346,000
Q1 2024

May 15, 2024

SELL
$63.75 - $108.06 $280,500 - $475,464
-4,400 Reduced 41.9%
6,100 $427,000
Q4 2023

Feb 14, 2024

BUY
$26.88 - $83.49 $282,240 - $876,645
10,500 New
10,500 $876,000
Q3 2022

Nov 14, 2022

BUY
$38.54 - $54.52 $19,270 - $27,260
500 New
500 $24,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.51B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.